قالب وردپرس درنا توس
Home / World / Why is Novavax stock up today?

Why is Novavax stock up today?



What happened

Shares of Novavax (NASDAQ: NVAX) 7% increase on Thursday after the biotech company reached a development and supply agreement with SK Bioscience, a subsidiary of South Korean giant SK group.

So what

SK Bioscience will produce the antigenic component of the experimental COVID-19 vaccine from Novavax, NVX-CoV2373. The two companies have also reached an agreement with the Korean Ministry of Health and Welfare to make the vaccine – if it is proven to be safe and effective – available in Korea and the international market.

A syringe draws liquid from the vial.

Novavax shares rose on news of a new coronavirus supply deal. Photo source: Getty Images.

“We are proud to partner with SK Bioscience to fulfill our commitment to securing NVX-CoV2373 supply globally,” Novavax CEO Stanley Erck said in a press release. “SK Bioscience shares our sense of urgency to ensure broad and equitable access to our COVID-19 vaccine candidate worldwide.”

So what now

Preliminary data from Novavax’s 1/2 phase trial show that their COVID-19 vaccine candidate produces a strong antibody response and is generally well tolerated. These results clearly attracted the interest of SK Group and the Korean government. Other governments have also shown interest in NVX-CoV2373; Novavax has also recently reached deals with Takeda Pharmaceutical and the Indian Private Serum Institute (SIIPL) to help bring its vaccine to Japan and India, if it gets regulatory approval.




Source link